Corcept Therapeutics
CORT
#2462
Rank
C$9.98 B
Marketcap
C$91.22
Share price
-2.09%
Change (1 day)
-14.63%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): C$0.15 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are C$0.96 Billion. In 2025 the company made an earning of C$64.23 Million a decrease over its 2024 earnings that were of C$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.15 B147.79%
2025 C$64.23 M-67.29%
2024 C$0.19 B27.66%
2023 C$0.15 B-4.75%
2022 C$0.16 B-9.51%
2021 C$0.17 B-2.91%
2020 C$0.18 B14.87%
2019 C$0.16 B24.71%
2018 C$0.12 B69.32%
2017 C$75.78 M419.26%
2016 C$14.59 M-395.64%
2015 -C$4.94 Million-87.53%
2014 -C$39.61 Million-33.44%
2013 -C$59.51 Million
2011 -C$46.37 Million17.84%
2010 -C$39.35 Million35.5%
2009 -C$29.04 Million2.84%
2008 -C$28.24 Million60.81%
2007 -C$17.56 Million-52.14%
2006 -C$36.69 Million20.91%
2005 -C$30.34 Million31.87%
2004 -C$23.01 Million60.54%
2003 -C$14.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.84 B 16,779.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$18.12 B 11,299.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$9.99 B 6,182.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$49.85 B 31,249.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.64 B 5,961.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.24 B 10,117.29%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-C$69.77 Million-143.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.11 B-28.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$62.61 M-60.63%๐Ÿ‡บ๐Ÿ‡ธ USA